[1] SVESTAK M, SPOROVA L, HEJDUK P, et al. Collagenous repeat-containing sequence of 26 kDa protein-a newly discovered adipokine-sensu lato-A minireview[J]. Biomed Pap Med Fac Univ PalackyOlomouc Czech Repub, 2010,154(3):199-202. [2] PETERSEN PS, WOLF RM, LEI X, et al. Immunomodu-latory roles of CTRP3 in endotoxemia and metabolic stress[J]. Physiol Rep, 2016,4(5):e12735-12747. [3] ZHANG R C, ZHONG L B, ZHOU J F, et al. Complement-C1q TNF-related protein 3 alleviates mesangial cell activation and inflammatory response stimulated by secretory IgA[J].Am J Nephrol, 2016,43(6):460-468. [4] LI X,JIANG L,YANG M, et al. CTRP3 modulates the expression and secretion of adipokinesin 3T3-L1 adipocytes[J]. Endocr J, 2014,61(12):1153-1162. [5] YING L, WRIGHT G L, PETERSON J M.C1q/TNF-related protein 3(CTRP3) function and regulation[J].Am J Physiol Regul Integr Comp Physiol, 2018,314(1):863-878. [6] MA Z G, YUAN Y P, XU S I, et al. CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats[J].Diabetologia, 2017, 60(6):1126-1137. [7] YANG Y, LI Y, MA Z Q, et al. A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection[J].Prog Lipid Res, 2016, 64(10):170-177. [8] YUAN Y P, MA Z G, ZHANG X, et al. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1[J].J Mol Cell Cardiol, 2018, 114(1):38-47. [9] 李新,孙家忠,孙苏欣,等.AMPK信号通路介导了CTRP3增加3T3-L1脂肪细胞脂联素表达的研究[J].国际内分泌代谢杂志,2014,34(1):15-17. [10] TAN B K, CHEN J, HU J, et al. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2013, 98(12):1891-1900. [11] ASEMI Z, FOROOZANFARD F, HASHEMI T, et al. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome[J]. Clin Nutr, 2015, 34(4):586-592. [12] SCHMIDA A, KOPP A, HANSES F,et al.C1q/TNF-related protein-3 attenuates lipopolysaccharide-induced systemic inflammation and adipose tissue Erk-1/-2 phosphorylation in mice in vivo[J]. Biochem Biophys Res Commun,2014,452(1):8-13. [13] PETERSON J M, SELDIN M M, WEI ZK, et al. CTRP3 attenuates dietinduced hepatic steatosis by regulating triglyceride metabolism[J]. Am J Physiol Gastrointest Liver Physiol, 2013, 305(3):214-224. [14] DENG W Q, LI C Y,ZHANG Y P, et al. Serum C1q/TNF-related protein-3(CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance[J]. Diabetol Metabol Syn, 2015,33(7):3-8. [15] FLEHMING G,SCHOLZ M, KLÖTING N, et al. Identification of adipokine clusters related to parameters of fat mass,insulin sensitivity and inflammation[J]. PLoS One,2014,9(6):e99785. [16] ZHANG J X, ZHANG B L, CHENG Y Y, et al. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Cytokine, 2018, 106(6):131-135. [17] MOOKKYUNGC,SOONYOUNGH,CHEOLHH,et al.C1q/TNF-related protein-3(CTRP-3) and pigment epithelium-derived factor(PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome[J]. Diabetes,2012,61(11):2932-2936. [18] BORNSTEDT M E,GJERLAUGSEN N, PEPAJ M, et al. Vitamin D increases glucose stimulated insulin secretion from insulin producing beta cells (INS1E)[J].Int J Endocrinol Metab, 2019, 17(1):e74255. [19] ABDELSADEK S E, EL SAGHIER E O, ABDEL RAHEEM S I.Serum 25(OH) vitamin D level and its relation to diabetic peripheral neuropathy in Egyptian patients with type 2 diabetes mellitus[J].Egypt J Neurol Psychiatr Neurosurg, 2018, 54(1):36-43. [20] WELDEGIORGIS T Z, HIDRU T H, YANG X L, et al. The association between serum 25-(OH) D concentrations and metabolic syndrome in the middle-aged and elderly chinese population in dalian, north-east China:A cross-sectional study[J].J Diabetes Investig, 2019.DOI:10.1111/jdi.13086. [21] SUNMIN PARK, DA SOL KIM, SUNA KANG. Vitamin D deficiency impairs glucose-stimulated insulin secretion and increasesinsulin resistance by reducing PPAR-γ expression in nonobese type 2 diabetic rats[J].J Nutrit Biochem,2016, 27(1):257-265. [22] WORTSMAN J,MATSUOKA L Y,CHEN T C,et al.Decreased bioavalability of vitamin D in obesity[J].Am J Clin Nutr,2000,72(3);690-693. [23] 赖勇昌,韩峰,张琳.血清维生素D与非酒精脂肪性肝病相关性研究[J].中国实用内科杂志,2019,39(6):285-287. |